Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gold

Showing results (751-760 of 753) with videos related to

Pageof 76
Sort By:
You have reached the last page of results.This site can display upto 753 results.
Journal of the American Academy of Dermatology|August 22, 2025
Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III studyTodd Schlesinger, M Shane Chapman, John H Tu, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Lasers in Surgery and Medicine|June 11, 2025
Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the FaceBianca Y Kang, Joel L Cohen, Roy Geronemus, et al.
Pageof 76

Showing results (751-760 of 753) with videos related to

Sort By:
Pageof 76
You have reached the last page of results.This site can display upto 753 results.
Journal of the American Academy of Dermatology|August 22, 2025
Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III studyTodd Schlesinger, M Shane Chapman, John H Tu, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Lasers in Surgery and Medicine|June 11, 2025
Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the FaceBianca Y Kang, Joel L Cohen, Roy Geronemus, et al.
Pageof 76